Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Morita, T.
Right arrow Articles by Chihara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, T.
Right arrow Articles by Chihara, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study

Tatsuya Morita

Junichi Tsunoda

Satoshi Inoue

Satoshi Chihara

Seirei Hospice, Seirei Mikatabara Hospital, Japan

Death rattle is frequently observed in cancer patients whose death is impending and may contribute to the severe distress of patients and their family members. To identify risk factors for development and persistency of death rattle, a prospective study was performed on 245 hospice inpatients.

One-hundred-and-seven patients (44%) developed death rattle, 71% of whom achieved satisfactory symptom palliation until death. A multiple regression analysis identified neoplasms of brain and lung as independent risk factors for development of death rattle, while refractory symptoms were significantly associated with pulmonary neoplasms and infection/oedema.

In conclusion, development of death rattle was influenced by both brain and lung malignancies, while its persistency was mainly determined by pulmonary pathology. A clinical classification of death rattle based on these factors would be established by a further confirmatory study.

Key Words: death rattle • neoplasms • terminal care

Palliative Medicine, Vol. 14, No. 1, 19-23 (2000)
DOI: 10.1191/026921600670897377
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
B. L Wee, P. Coleman, R Hillier, and S. Holgate
The sound of death rattle I: are relatives distressed by hearing this sound?
Palliative Medicine, April 1, 2006; 20(3): 171 - 175.
[Abstract] [PDF]

Home page
 Palliat MedHome page
M. Bennett, V. Lucas, M. Brennan, A. Hughes, V. O'Donnell, and B. Wee
Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care
Palliative Medicine, July 1, 2002; 16(5): 369 - 374.
[Abstract] [PDF]